Fast
Etiology
Suspected MASLD patients (Formerly NAFLD)
Target
MASH + NAS≥4 + F≥2
Uses
Screening for clinical trial and identifying at-risk MASH patients
FibroScan® results (LSM by VCTE™ & CAP™) + laboratory parameter (AST)
Reference
Fast is a formula published and validated in multiple studies. Fast: princeps paper - Newsome et al., Lancet